Monday, July 26, 2004

From the Canadian Press:
Merck, Schering-Plough launch new, combination cholesterol pill
Vytorin, the first pill to lower cholesterol in two ways, should hit pharmacy shelves within weeks, the makers said Monday as they promised heavy marketing and a discounted price to battle the top-selling competition.

A joint venture between pharmaceutical companies Merck & Co. and Schering-Plough Corp. won Food and Drug Administration approval late Friday for Vytorin as a supplement to dieting - an approval crucial for both companies.

No comments: